scholarly journals Spine Treatment Appraisal Report (STAR): Does Marijuana Use Affect Postoperative Outcomes in Patients Receiving Transforaminal Lumbar Interbody Fusion (TLIF)?

2021 ◽  
pp. 219256822199740
Author(s):  
Joseph R. Dettori
Keyword(s):  
Spinal Fusion ◽  
Interbody Fusion ◽  
Marijuana Use ◽  
Transforaminal Lumbar Interbody Fusion ◽  
Postoperative Outcomes ◽  
Lumbar Interbody Fusion ◽  
Lumbar Spinal Fusion ◽  
Lumbar Spinal

Jakoi AM, Kirchner GJ, Kerbel YE, Iorio JA, Khalsa AS. The effects of marijuana use on lumbar spinal fusion. Spine (Phila Pa 1976). 2020;45(9):629-634.

scholarly journals New combination of IntraSPINE device and posterior lumbar interbody fusion for rare skipped-level lumbar disc herniation: a case report and literature review

2020 ◽  
Vol 48 (8) ◽  
pp. 030006052094976
Author(s):  
Shitong Feng ◽  
Zihan Fan ◽  
Jiashuai Ni ◽  
Yong Yang ◽  
Qi Fei
Keyword(s):  
Spinal Fusion ◽  
Lumbar Disc Herniation ◽  
Disc Herniation ◽  
Interbody Fusion ◽  
Lumbar Disc ◽  
Posterior Lumbar Interbody Fusion ◽  
Lumbar Interbody Fusion ◽  
Lumbar Spinal Fusion ◽  
Degenerative Lumbar Disease ◽  
Lumbar Spinal

Posterior lumbar interbody fusion is an open surgical technique that has been widely used for the treatment of degenerative lumbar disease. However, traditional lumbar spinal fusion, especially long-segment fusion surgery, is associated with several complications. The IntraSPINE (Cousin Biotech, Wervicq-Sud, France) is a new device for non-fusion lumbar spine surgery that is used as an alternative for the treatment of degenerative lumbar disease. Although the designer of the IntraSPINE proposed indications for its use, including combination of the device with lumbar spinal fusion for the treatment of degenerative lumbar disease, use of the IntraSPINE has not been reported in the clinical literature. In the present case, we boldly combined the IntraSPINE device and posterior lumbar interbody fusion for the treatment of skipped-level lumbar disc herniation to explore the indications of the IntraSPINE and report its clinical outcomes.

scholarly journals Clinical Outcomes of Posterior Lumbar Interbody Fusion versus Minimally Invasive Transforaminal Lumbar Interbody Fusion in Three-Level Degenerative Lumbar Spinal Stenosis

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Guoxin Fan ◽  
Xinbo Wu ◽  
Shunzhi Yu ◽  
Qi Sun ◽  
Xiaofei Guan ◽  
...  
Keyword(s):  
Blood Loss ◽  
Spinal Stenosis ◽  
Lumbar Spinal Stenosis ◽  
Interbody Fusion ◽  
Posterior Lumbar Interbody Fusion ◽  
Transforaminal Lumbar Interbody Fusion ◽  
Lumbar Interbody Fusion ◽  
Degenerative Lumbar Spinal Stenosis ◽  
Sf 36 ◽  
Lumbar Spinal

The aim of this study was to directly compare the clinical outcomes of posterior lumbar interbody fusion (PLIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) in three-level lumbar spinal stenosis. This retrospective study involved a total of 60 patients with three-level degenerative lumbar spinal stenosis who underwent MIS-TLIF or PLIF from January 2010 to February 2012. Back and leg visual analog scale (VAS), Oswestry Disability Index (ODI), and Short Form-36 (SF-36) scale were used to assess the pain, disability, and health status before surgery and postoperatively. In addition, the operating time, estimated blood loss, and hospital stay were also recorded. There were no significant differences in back VAS, leg VAS, ODI, SF-36, fusion condition, and complications at 12-month follow-up between the two groups (P>0.05). However, significantly less blood loss and shorter hospital stay were observed in MIS-TLIF group (P<0.05). Moreover, patients undergoing MIS-TLIF had significantly lower back VAS than those in PLIF group at 6-month follow-up (P<0.05). Compared with PLIF, MIS-TLIF might be a prior option because of noninferior efficacy as well as merits of less blood loss and quicker recovery in treating three-level lumbar spinal stenosis.

Sign in / Sign up

Export Citation Format

Share Document